Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long QT Syndrome (LQTS) 2”

4 trials

Showing 4 of 4 results

Early research (Phase 1)Study completedNCT02365506
What this trial is testing

Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome

Who this might be right for
LQT2 Syndrome
Gilead Sciences 13
Testing effectiveness (Phase 2)Ended earlyNCT05906732
What this trial is testing

Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).

Who this might be right for
Long QT Syndrome
Thryv Therapeutics, Inc. 42
Not applicableLooking for participantsNCT07075445
What this trial is testing

Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3

Who this might be right for
Long QT Syndrome Type 3Long QT Syndrome 2
Thryv Therapeutics, Inc. 200
Large-scale testing (Phase 3)Looking for participantsNCT07277582
What this trial is testing

Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)

Who this might be right for
Long QT Syndrome (LQTS) 2
Thryv Therapeutics, Inc. 84

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation